Variable | TOTAL N = 60 | Non-Responders N = 33 | Responders N = 27 | p |
---|---|---|---|---|
Age (years) | 79 [70–87] | 80 [67–88] | 77 [71–86] | 0.806 |
Male sex, n (%) | 24 (40) | 15 (46) | 9 (33) | 0.340 |
CD4 + T-cell count (cells/mm 3 ) | 799 [614–1103] | 715 [533–1236] | 825 [749–1008] | 0.281 |
CD8 + T-cell count (cells/mm 3 ) | 473 [279–685] | 439 [159–671] | 486 [384–698] | 0.185 |
CD4 + /CD8 + ratio | 1.8 [1.2–2.3] | 1.9 [1.2–2.3] | 1.6 [1.1–2.7] | 0.704 |
sj/β TREC ratio | 32 [0–50] | 31 [0–55] | 34 [7–50] | 0.615 |
Thymic failure a | 19 (32) | 12 (36) | 7 (27) | 0.441 |
CMV titre (AU/μL) | 25.4 [13.3–40.3] | 25.4 [12.4–39.0] | 24.6 [13.8–43.0] | 0.973 |
LBP (ng/μL) | 12.7 [10.2–14.1] | 13.0 [10.1–15.3] | 12.7 [11.4–13.5] | 0.564 |
hsCRP (mg/L) | 2.8 [1.6–5.0] | 2.3 [1.2–4.8] | 3.1 [2.2–5.0] | 0.330 |
B2M (μg/mL) | 2.5 [2.1–3.5] | 2.7 [2.4–3.7] | 2.3 [2.0–3.3] | 0.156 |
D-dimers (μg/L) | 705 [438–1183] | 875 [445–1425] | 620 [438–918] | 0.082 |
IL-6 (pg/mL) | 3.5 [2.4–4.6] | 3.4 [2.3–4.9] | 3.6 [2.6–4.5] | 0.691 |
sCD163 (ng/L) | 1034 [844–1293] | 1034 [792–1224] | 1084 [878–1477] | 0.222 |
% Lymphocytes | 26.2 [23.2–33.1] | 24.9 [22.4–32.0] | 29.0 [25.0–34.1] | 0.063 |
% Monocytes | 6.5 [5.4–7.6] | 6.6 [5.4–7.9] | 6.5 [5.4–7.5] | 0.894 |
% Neutrophils | 59.6 [54.1–65.7] | 62.8 [54.4–66.9] | 58.0 [52.4–62.5] | 0.089 |
% Basophils | 0.2 [0.2–0.4] | 0.3 [0.2–0.4] | 0.2 [0.1–0.3] | 0.258 |
% Eosinophils | 3.4 [2.2–4.2] | 3.2 [1.7–4.5] | 3.7 [3.2–4.2] | 0.094 |
Platelets (x10e9/L) | 223 [180–294] | 233 [181–294] | 197 [170–296] | 0.650 |
MCV (fL) | 90.2 [86.1–93.6] | 90.6 [85.5–93.5] | 90.0 [86.6–95.1] | 0.876 |
MPV (fL) | 9.4 [7.9–10.1] | 9.3 [7.8–10.3] | 9.40 [8.1–10.0] | 0.716 |
ESR (mm/h) | 12 [6–22] | 14 [6–21] | 10 [6–24] | 0.921 |
PLR | 117 [87–164] | 134 [88–166] | 113 [82–144] | 0.377 |
NLR | 2.3 [1.6–2.9] | 2.6 [1.7–3.0] | 1.9 [1.5–2.4] | 0.056 |
Comorbidities (number b ) | 3 [2–5] | 3 [2–5] | 3 [2–5] | 0.874 |
Barthel index c | 87 [70–100] | 85 [70–100] | 90 [70–100] | 0.838 |
< 20 | 3 (5) | 1 (3.8) | 2 (6.1) | |
20–35 | 2 (3.3) | 1 (3.8) | 1 (3) | |
40–55 | 5 (8.3) | 3 (11.5) | 2 (6.1) | |
≥ 60 | 32 (53.3) | 14 (53.8) | 18 (54.5) | |
100 | 18 (30) | 8 (29.6) | 10 (30.3) |